Search Within

Charlotte Eielson Ariyan

  1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (16)
  3. Editorial (2)
  4. Research Letter (2)
  5. Guidelines (1)
Groups
  1. Department of Medicine (47)
  2. Melanoma Disease Management Team (47)
  3. Melanoma and Immunotherapeutics Service (47)
  4. Solid Tumor Oncology Division (47)
  5. Surgery (47)
  6. GSK Faculty (33)

More Groups

People
  1. Jedd Wolchok (28)
  2. Michael Postow (22)
  3. Daniel Coit (19)
  4. Margaret Callahan (17)
  5. Alexander Shoushtari (16)
  6. Katherine Panageas (15)

More People

Years
  1. 2023 (3)
  2. 2022 (5)
  3. 2021 (5)
  4. 2020 (4)
  5. 2019 (3)
  6. 2018 (6)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Annals of Surgical Oncology (9)
  3. Cancer Immunology Research (3)
  4. Nature (3)
  5. Nature Genetics (2)
  6. Nature Medicine (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. Springer (9)
  3. Nature Publishing Group (8)
  4. American Association for Cancer Research (5)
  5. Elsevier Inc. (2)
  6. Oxford University Press (2)

More Publishers

Results (47)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Most large structural variants in cancer genomes can be detected without long reads
    Journal Article

    Choo, Z. N.; Behr, J. M.; Deshpande, A.; Hadi, K.; Yao, X.; Tian, H.; Takai, K.; Zakusilo, G.; Rosiene, J.; Da Cruz Paula, A.; more...
    Nature Genetics (2023)

    Fulltext@MSK | Save
  • Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)
    Editorial

    Wei, A. Z.; Chen, L. N.; Orloff, M.; Ariyan, C. E.; Asgari, M.; Barker, C. A.; Buchbinder, E.; Chandra, S.; Couts, K.; Frumovitz, M. M.; more...
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • A phase II randomized trial of talimogene laherparepvec (T-VEC) oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Meeting Abstract

    Barker, C. A.; D'Angelo, S. P.; Steckler, A. M.; Lian, M.; Wasilewski, G.; Lacouture, M. E.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Neoadjuvant relatlimab and nivolumab in resectable melanoma
    Journal Article

    Amaria, R. N.; Postow, M.; Burton, E. M.; Tezlaff, M. T.; Ross, M. I.; Torres-Cabala, C.; Glitza, I. C.; Duan, F.; Milton, D. R.; Busam, K.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma
    Research Letter

    Kurtansky, N. R.; Manci, R. N.; Bello, D. M.; Adamson, A. S.; Shoushtari, A. N.; Wehner, M. R.; Ariyan, C. E.; Marghoob, A. A.; Marchetti, M. A.; Rotemberg, V.
    British Journal of Dermatology (2022)

    Fulltext@MSK | Save
  • T-VEC treatment reverses PD-1 resistance by altering the microenvironment of tumors
    Meeting Abstract

    Theriot, J.; Hu, J.; Wong, R. J.; Wolchok, J.; Rudensky, A.; Ariyan, C.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Anatomic position determines oncogenic specificity in melanoma
    Journal Article

    Weiss, J. M.; Hunter, M. V.; Cruz, N. M.; Baggiolini, A.; Tagore, M.; Ma, Y.; Misale, S.; Marasco, M.; Simon-Vermot, T.; Campbell, N. R.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Tumor MHC class I expression associates with intralesional IL2 response in melanoma
    Journal Article

    Pourmaleki, M.; Jones, C. J.; Ariyan, C. E.; Zeng, Z.; Pirun, M.; Navarrete, D. A.; Li, Y.; Zhang, M.; Nandakumar, S.; Campos, C.; more...
    Cancer Immunology Research (2022)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant nivolumab (nivo) with anti-LAG3 antibody relatlimab (rela) for patients (pts) with resectable clinical stage III melanoma
    Meeting Abstract

    Amaria, R. N.; Postow, M. A.; Tetzlaff, M. T.; Ross, M. I.; Glitza, I. C.; McQuade, J. L.; Wong, M. K. K.; Gershenwald, J. E.; Goepfert, R.; Keung, E. Z. Y.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
    Journal Article

    Andrews, M. C.; Duong, C. P. M.; Gopalakrishnan, V.; Iebba, V.; Chen, W. S.; Derosa, L.; Khan, M. A. W.; Cogdill, A. P.; White, M. G.; Wong, M. C.; more...
    Nature Medicine (2021)

    Fulltext@MSK | Save